Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study

BACKGROUND/AIMS: Prospective data on switching anti-vascular endothelial growth factors in patients with neovascular age-related macular degeneration (nAMD) who have previously shown no/partial response are limited. This prospective study assessed the effect of switching from aflibercept to ranibizu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br J Ophthalmol
Päätekijät: Gale, Richard P, Pearce, Ian, Eter, Nicole, Ghanchi, Faruque, Holz, Frank G, Schmitz-Valckenberg, Steffen, Balaskas, Konstantinos, Burton, Ben J L, Downes, Susan M, Eleftheriadis, Haralabos, George, Sheena, Gilmour, David, Hamilton, Robin, Lotery, Andrew J, Patel, Nishal, Prakash, Priya, Santiago, Cynthia, Thomas, Saju, Varma, Deepali, Walters, Gavin, Williams, Michael, Wolf, Armin, Zakri, Rosina H, Igwe, Franklin, Ayan, Filis
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2020
Aiheet:
Clinical Science
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7147176/
https://ncbi.nlm.nih.gov/pubmed/31383649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2019-314251
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia